Perioperative Respiratory Support and Postoperative Outcomes
RuVent-A
1 other identifier
observational
1,000
0 countries
N/A
Brief Summary
This study aims to evaluate the methodology and parameters of perioperative respiratory support (RS) and the frequency of postoperative pulmonary complications (PPCs) in the Russian Federation. The study will analyze respiratory support strategies, equipment availability, and their correlation with PPC outcomes in surgical patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2025
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 22, 2025
CompletedFirst Posted
Study publicly available on registry
January 29, 2025
CompletedStudy Start
First participant enrolled
April 7, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 11, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 11, 2025
CompletedJanuary 29, 2025
January 1, 2025
4 days
January 22, 2025
January 27, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of Postoperative Pulmonary Complications (PPCs)
The frequency of postoperative pulmonary complications (PPCs) will be measured, including conditions such as atelectasis, hypoxemia, pneumonia, acute respiratory distress syndrome (ARDS), and bronchospasm. PPCs will be evaluated based on clinical and diagnostic criteria following surgery.
30 days after surgery
Secondary Outcomes (7)
Level of end-expiratory pressure during anesthesia
During surgery (intraoperative period).
Use of Alveolar Recruitment Maneuvers During Anesthesia
During surgery (intraoperative period).
Frequency of Non-Invasive Ventilation and High-Flow Oxygen Therapy Post-Extubation
30 days after surgery
Duration of Intraoperative and Postoperative Mechanical Ventilation
Intraoperative and up to 24 hours postoperatively.
Incidence of Hypoxemia Post-Surgery
30 days after surgery
- +2 more secondary outcomes
Eligibility Criteria
The study population will include adult patients (aged ≥18 years) undergoing surgical procedures under general anesthesia with respiratory support in participating medical centers across the Russian Federation. The study will focus on a wide range of surgical specialties, including but not limited to general surgery, orthopedics, neurosurgery, vascular surgery, and thoracic surgery. Patients with various comorbidities (e.g., obesity, chronic obstructive pulmonary disease, smoking, sleep apnea) that may influence respiratory support strategies will be included to provide a comprehensive assessment of perioperative respiratory management and its outcomes. No specific exclusion criteria will be applied, allowing for the inclusion of a diverse and representative cohort of surgical patients.
You may qualify if:
- Patients aged ≥18 years undergoing surgical procedures with general anesthesia and respiratory support.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Officials
- PRINCIPAL INVESTIGATOR
Andrey Yaroshetskiy, MD
Sechenov First Moscow State Medical University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 22, 2025
First Posted
January 29, 2025
Study Start
April 7, 2025
Primary Completion
April 11, 2025
Study Completion
May 11, 2025
Last Updated
January 29, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share
Individual Participant Data (IPD) Sharing Statement Individual participant data (IPD) will not be shared due to the following reasons: Privacy and Confidentiality: The study involves sensitive patient data, and ensuring patient confidentiality is a top priority. Although the data will be anonymized, sharing IPD could still pose risks of re-identification. Regulatory and Ethical Considerations: Sharing IPD may not comply with local regulations and ethical guidelines governing patient data use in the Russian Federation. Study Scope: The primary objective of this study is to analyze aggregated data to inform clinical practices rather than to enable secondary analyses or external collaborations.